Microrna-490-5p Inhibits Invasion and Migration of Human Intrahepatic Cholangiocarcinoma RBE Cells

XU Yi,ZHANG Yichi,WANG Xu'an,LIU Yingbin
DOI: https://doi.org/10.3781/j.issn.1000-7431.2017.11.140
2017-01-01
Tumor
Abstract:Objective:To investigate the expression of microRNA-490-5p (miR-490-5p) in human intrahepatic cholangiocarcinoma tissues,and to study its impacts on invasion and migration of intrahepatic cholangiocarcinoma RBE cells and the underlying molecular mechanism.Methods:The expression level of miR-490-5p in 5 pairs of intrahepatic cholangiocarcinoma tissues and the adjacent normal tissues was detected by real-time fluorescent quantitative PCR.Intrahepatic cholangiocarcinoma RBE cells were transfected with miR-490-5p-mimics and the negative control by LipofectAMINE 2000,respectively.Then the cell migration and invasion abilities were explored by scratch wound healing assay and Transwell chamber assay,the proliferation of RBE cells were measured by CCK-8 assay,the colony formation ability was detected by colony formation assay,the apoptosis rate was detected by FCM method.The target genes of miR-490-5p were predicted by online miRNA-targeted gene prediction software,and validated by Western blotting.Results:The expression level of miR-490-5p was significantly down-regulated in human intrahepatic cholangiocarcinoma tissue as compared with the adjacent normal tissues (P < 0.05).After transfection with miR-490-5p-mimics,the proliferation,colony forming and apoptosis of RBE cells were not significantly changed (all P > 0.05),but the scratch healing,migration and invasion abilities of RBE cells were significantly decreased (all P < 0.05).TargetScan website predicted that the potential target gene of miR-490-5p was FBJ osteosarcoma oncogene (c-Fos),and Western blotting verified that the expression of c-Fos was significantly down-regulated in RBE cells transfected with miR-490-5p-mimics.Conclusion:miR-490-5p is lowly expressed in human intrahepatic cholangiocarcinoma,and may regulate the migration and invasion of intrahepatic cholangiocarcinoma RBE cells by down-regulating the expression of c-Fos gene.
What problem does this paper attempt to address?